Scientists discover new arenavirus associated with hemorrhagic fever

A team of Bolivian health authorities, U.S. Navy health experts based in Lima, Peru, and the U.S. Centers for Disease Control and Prevention has characterized “Chapare arenavirus,” a previously unrecognized arenavirus, discovered in serum samples from a patient in rural Bolivia who eventually died of the infection. A full report of the study is published April 18th in the open-access journal PLoS Pathogens.

Named after the Chapare River in the eastern foothills of the Andes, the new Chapare arenavirus produces clinical hemorrhagic symptoms similar to those associated with other New World arenaviruses, such as the Junin, Machupo, Guanarito, and Sabia viruses. Genetically, however, Chapare is different from each.

Junin, Machupo and Guanarito viruses have been associated with large outbreaks of hemorrhagic fever. Initial symptoms often include fever, malaise, muscle aches, nausea, vomiting, and anorexia, followed later by hemorrhagic symptoms. Untreated, more severe neurologic and/or hemorrhagic symptoms may develop, and death occurs in up to 30%.

In this study, the authors first tested for yellow fever and dengue hemorrhagic fevers, but results were negative. Tests for Machupo and other related viruses also were negative. Sequence analysis of specific segments of the virus later confirmed it as a unique member of the Clade B New World Arenaviruses.

Due to the remote nature of the region where the case occurred, only a limited description of a possible cluster of cases in the area was determined.

“Further surveillance and ecological investigations should clarify the nature of the health threat posed by the Chapare virus, and give us better information on the source of human infection,” says CDC virologist Tom Ksiazek of the Special Pathogens Branch.

“We need to learn more about this virus: how it is related to the other arenaviruses, how it causes disease, where it lives in nature,” says Ksiazek. “Together with our colleagues in Bolivia and Peru, we’re anticipating a more intensive investigation that improves our understanding of the virus, the disease it causes, and its ecology.”

Source: Public Library of Science

Related stories:

Arrival method, slow response often delay stroke care
Most stroke patients can't recall when their symptoms started or do not arrive at the hospital in a timely manner, so they cannot be considered for time-dependent therapies such as the clot-busting drug tissue plasminogen activator (tPA), researchers reported in Stroke: Journal of the American Heart Association.
Old antibiotic may find new life as a stroke treatment
An old intravenous antibiotic may have new life as a stroke treatment, researchers say. Minocycline appears to reduce stroke damage in multiple ways – inhibiting white blood cells and enzymes that, at least acutely, can destroy brain tissue and blood vessels, respectively, says Dr. David Hess, chair of the Department of Neurology in the Medical College of Georgia School of Medicine. The broad-spectrum antibiotic also seems to reduce cell suicide in the minutes and hours following a stroke, enabling more cells to recover.
Deadly fish virus VHSV spreading throughout Great Lakes Basin
A lethal fish virus in the Great Lakes and neighboring waterways is approaching epidemic proportions, according to Paul Bowser, Cornell professor of aquatic animal medicine in the College of Veterinary Medicine. The viral hemorrhagic septicemia virus (VHSV), which causes anemia and hemorrhaging in fish, has now been identified in 19 species and poses a potential threat to New York's $1.2 billion sport-fishing industry.
Pattern of Human Ebola Outbreaks Linked to Wildlife and Climate
A visiting biologist at the University of California, San Diego and her colleagues in Africa and Britain have shown that there are close linkages between outbreaks of Ebola hemorrhagic fever in human and wildlife populations, and that climate may influence the spread of the disease.
Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack
Mass vaccination would not be necessary in the event of a large-scale smallpox bioterrorist attack in the United States, according to a study led by researchers at Fred Hutchinson Cancer Research Center that appears online in the International Journal of Infectious Diseases.
Hantavirus found in African wood mouse
Scientists have reported the discovery of the first African hantavirus, a type of rodent-borne virus that can cause life-threatening infections in humans.
Researchers report breakthrough vaccines against world's deadliest viruses
New Ebola, Marburg Vaccines effective in animal models

Scientists from the Public Health Agency of Canada - with assistance from the U.S. Army Medical Research Institute of Infectious Diseases - have developed vaccines against the Ebola and Marburg viruses that have been shown to be effective in non-human primates.
In a study published in this month's Nature Medicine, Canadian researchers Dr. Heinz Feldmann and Dr. Steven Jones of PHAC's National Microbiology Laboratory and Dr. Thomas Geisbert of USAMRIID report that the vaccines have proven 100 percent effective in protecting monkeys against infection from these often deadly viruses.
Alcohol's impact on heart and stroke risk may differ for men, women
The volume of alcohol consumption may have a significantly different effect on heart and stroke risk in men and women, according to a study of Japanese people published in Stroke: Journal of the American Heart Association.

News discussion:

Medicine & Health news